Use of superficial radiation therapy for treatment of eyelid squamous cell carcinoma in the horse
The goal of this study is show the safety and efficacy of superficial radiation therapy for treatment of eyelid squamous cell carcinoma. Superficial radiation therapy (SRT) uses a focal beam of radiation to treat a small area of the eyelid that has the tumor. The SRT quickly delivers radiation to the tumor and can be performed on the standing horse while sedated. This therapy may be effective for tumors that have failed to respond to other therapies. The cost of the radiation therapy is covered by the study.
condition(s)
eligibility information
Your horse should be systemically healthy as determined by a physical exam and blood work (complete blood count and serum chemistry). Your horse must have a biopsy of the eyelid tumor confirming it is squamous cell carcinoma prior to the enrollment.
Enrollment Deadline
Enrollment ends August 1, 2024
contact information
